#texastech

Health & Fitness | Vaccine information

Texas Tech Health Sciences Center Researcher Receives NIH Grant for Vaccine

The three-year NIAID/SBIR-R44 Phase II Grant is to prepare the Schistosomiasis Vaccine (SchistoShield®) for human clinical trials